Summit Therapeutics (NASDAQ:SMMT) Showcases Promising Data at J.P. Morgan Healthcare Conference
Summit Therapeutics recently presented their latest developments at the 43rd Annual J.P. Morgan Healthcare Conference. The event featured discussions led by Bob Duggan, the Chairman & CEO, and Dr. Maky Zanganeh, the CEO & President. During the presentation, Summit Therapeutics outlined their future expectations and strategic plans surrounding the clinical and preclinical development of their […]
More Stories
Pines Wealth Management LLC Buys Shares of 2,725 The Goldman Sachs Group, Inc. (NYSE:GS)
Pines Wealth Management LLC purchased a new position in The Goldman Sachs Group, Inc. (NYSE:GS – Free Report) during the...
Sovereign Financial Group Inc. Acquires 1,549 Shares of JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI)
Sovereign Financial Group Inc. raised its holdings in JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI – Free Report) by 7.0% during...
Covea Finance Increases Stake in Becton, Dickinson and Company (NYSE:BDX)
Covea Finance increased its position in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 6.0% during the...
First Community Trust NA Acquires 185 Shares of Becton, Dickinson and Company (NYSE:BDX)
First Community Trust NA boosted its stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 2.6%...
Moseley Investment Management Inc. Boosts Stake in Vanguard Total World Stock ETF (NYSEARCA:VT)
Moseley Investment Management Inc. raised its position in shares of Vanguard Total World Stock ETF (NYSEARCA:VT – Free Report) by...
Plato Gold (CVE:PGC) Shares Down 20% – Here’s What Happened
Plato Gold Corp. (CVE:PGC – Get Free Report) shares dropped 20% on Wednesday . The company traded as low as...